Position in SCLX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$171
+$12 QoQ
Shares Held
22
-43.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 72 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NFSG Corp holds $13,230,148 across 16 Drug Manufacturers - General names. SCLX ranks #16 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,038 | $6,042,728 | |
| 2 | ABBV |
AbbVie Inc.
|
9,066 | $2,281,368 | |
| 3 | JNJ |
Johnson & Johnson
|
7,757 | $1,970,045 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,054 | $1,677,439 | |
| 5 | PFE |
Pfizer Inc
|
12,510 | $301,240 | |
| 6 | AMGN |
Amgen Inc
|
716 | $259,277 | |
| 7 | GSK |
GSK plc
|
4,417 | $231,539 | |
| 8 | AZN |
Astrazeneca PLC
|
1,128 | $213,891 |
All Filings in SCLX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $171 | 22 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $159 | 24 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $292 | 24 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $472 | 24 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $147 | 25 | Shares | Sole | 2025-08-19 | |
| No filing history on record for this holder in this stock. | ||||||